{
  "catalogId": "a4af011d-9962-44f5-82f3-17f15af85270",
  "name": "FABRAZYME 35 MG",
  "status": "draft",
  "category": "prescription",
  "registrationValidity": "valid",
  "registrationNumber": "124 94 30313 00",
  "treatmentDescriptions": "Fabrazyme is indicated for use as long-term enzyme replacement therapy in patients with a confirmed diagnosis of Fabry disease. (alfa - galactosidase A deficiency).",
  "termsOfIssue": "Prescription required",
  "form": "powder for concentrate for solution for infusion",
  "route": "i.v",
  "site": "",
  "method": "",
  "administrationNotes": "",
  "ingredients": "AGALSIDASE BETA/VIAL",
  "codes": {
    "atc5": {
      "system": "WHO ATC Classification",
      "code": "A16AB04",
      "name": "AGALSIDASE BETA"
    }
  },
  "contraindications": "",
  "sideEffect": "",
  "warnings": "תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת",
  "alternativeMedications": [],
  "packaging": [
    {
      "name": "FABRAZYME 35MG/VIAL",
      "manufacturer": {
        "name": "סאנופי אוונטיס",
        "countryOfOrigin": "IL"
      },
      "strength": [
        {
          "value": 35.0,
          "unit": "mg"
        }
      ],
      "quantity": {
        "value": 1.0,
        "unit": "units"
      },
      "packagingDescription": "VIAL GLASS TYPE I",
      "shelfLife": "36",
      "storageConditions": "",
      "codes": {
        "moh": "6737",
        "yarpa": "11481",
        "pharmasoft": "6478",
        "barcode": "7290013773029"
      },
      "manufacturersAdministrationRecommendation": "",
      "pricing": {
        "currency": "ILS",
        "maxWholesalePrice": 10152.67183,
        "retailMargin": 10.0,
        "maxRetailPrice": 11167.93901,
        "maxPriceWithVAT": 13178.16745
      },
      "formulation": ""
    }
  ],
  "metadata": {
    "version": "1.5",
    "lastUpdated": "2025-08-01T18:03:52.554843"
  }
}